Which is better, ANAB or MTD?

On the Buffett-Fit framework, Mettler-Toledo International Inc. (MTD) currently grades higher than ANAB — 69/100 (B grade) vs 29/100 (F). That said, "better" depends on which framework you trust — ANAB wins on Benjamin Graham and Peter Lynch; MTD wins on Warren Buffett, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy ANAB or MTD?

This page is an educational comparison, not investment advice. Both ANAB and MTD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is ANAB better than MTD for value investing?

On the Buffett-style value-investing framework, MTD currently grades higher — 69/100 vs 29/100, a 40-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between ANAB and MTD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). ANAB currently scores 29/100 (F grade); MTD scores 69/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, ANAB or MTD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. ANAB and MTD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, ANAB or MTD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are ANAB and MTD both Healthcare stocks?

Yes — both AnaptysBio, Inc. (ANAB) and Mettler-Toledo International Inc. (MTD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this ANAB vs MTD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

AnaptysBio

Mettler-Toledo International

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

ANAB

AnaptysBio

Market cap

$2.57B

Sector

Healthcare

MTD

Mettler-Toledo International

Market cap

$22.29B

Sector

Healthcare

Overall winner

Mettler-Toledo International MTD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	ANAB	MTD	Winner
Warren Buffett	29F	69B	MTD
Benjamin Graham	66D	65B	ANAB
Philip Fisher	43D	63C	MTD
Peter Lynch	77B	66B	ANAB
Joel Greenblatt	54C	68B	MTD
Charlie Munger	35D	74B	MTD
Terry Smith	30F	70B	MTD

Side-by-side metrics

Metric	ANAB	MTD
Market cap	$2.57B	$22.29B
P/E (TTM)	-	25.3x
EV/EBIT	55.0x	21.6x
ROIC (TTM)	14.06%	36.09%
Gross margin	116.42%	57.79%
Net margin	-11.53%	21.4%
Revenue CAGR 5y	38.82%	2.01%
EPS CAGR 5y	-	6.12%
Debt / Equity	21.8x	-
Dividend yield	0.0%	0.0%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

ANAB leads on

P/E (TTM)-vs 25.3x+139%
Revenue CAGR 5y38.82%vs 2.01%+95%
Gross margin116.42%vs 57.79%+50%

MTD leads on

Net margin21.4%vs -11.53%+154%
Debt / Equity-vs 21.8x+141%
Market cap$22.29Bvs $2.57B+88%
ROIC (TTM)36.09%vs 14.06%+61%

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

AnaptysBio

Mettler-Toledo International

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like ANAB

More like MTD

Related on invest-like

Key terms in this analysis